MP

Madhusoodanan Pillai Murukesan Pillai

Active Director Designated Partner DIN 11200989
DIN 11200989 First appointment Jun 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Madhusoodanan Pillai Murukesan Pillai

Data last updated:

Madhusoodanan Pillai Murukesan Pillai is a Designated Partner at Neora Medtech Llp (since 2025).

DIN 11200989
Primary Designation Designated Partner
First Appointment 18 Jun 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 Jun 2025Active

Board colleagues of Madhusoodanan Pillai Murukesan Pillai

NameDINCompanyDesignation
Aniyan Pappy10710600Neora Medtech LlpDesignated Partner
Porinchu Thekkath Shensy11194284Neora Medtech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Neora Medtech Llp
Premium access

Shareholding and investment profile for Madhusoodanan Pillai Murukesan Pillai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madhusoodanan Pillai Murukesan Pillai

Madhusoodanan Pillai Murukesan Pillai currently holds 1 directorship: Neora Medtech Llp (Designated Partner, since 18 Jun 2025).

Madhusoodanan Pillai Murukesan Pillai was first appointed on 18 Jun 2025 as Designated Partner at Neora Medtech Llp.

The current boards of Madhusoodanan Pillai Murukesan Pillai's companies include Aniyan Pappy (Neora Medtech Llp), Porinchu Thekkath Shensy (Neora Medtech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available